Early-stage companies spend heavily on development before they earn revenue or pay tax, which is when an R&D incentive matters most. After this module you will be able to judge, before anyone gathers records, whether a claim is worth the effort: what form the benefit takes, whether a loss-making company can receive it as cash, what conditions attach, and the signs that a claim is not justified yet.
What this module covers
- Why a company with no tax to pay can still receive a benefit.
- What a loss-making company receives in each of the seven countries, in verified wording.
- The adjustments that separate a headline rate from cash.
- Six signals that the effort is not justified, or not justified yet.
Why a loss-making company can still benefit
An R&D incentive turns eligible costs into a benefit. For a profitable company it reduces a tax bill. For a company with no tax to pay, the benefit is worth something now only if the scheme does one of three things with it.
- Pays it out. The benefit is refundable, payable in cash or convertible into a cash payout, usually subject to a condition (turnover, a minimum spend, local employees) and often to a cap.
- Sets it against another liability. A credit that cannot reduce income tax may be applied against payroll taxes.
- Carries it forward. The benefit waits for profits, and in several countries survives only if continuity of ownership or shareholding tests are met, which a funding round can disturb.
What a loss-making company receives in each country
| Country | Benefit for a loss-making company | Conditions and caps |
|---|---|---|
| United States | Income tax credit. Not refundable. Qualified small businesses can elect to apply up to US$500,000 a year against payroll tax, using Form 8974. | Gross receipts of less than 5 million US dollars for the taxable year and no gross receipts for any taxable year preceding the five-taxable-year period ending with the taxable year. The election is made on a timely filed original return. |
| United Kingdom | Refundable: yes. A 20% expenditure credit, taxable. ERIS gives an additional deduction and a payable credit worth up to 14.5% of the surrenderable loss. | Payable credits are capped at £20,000 plus 300% of the company's relevant PAYE and National Insurance liabilities. ERIS is for loss-making SMEs whose relevant R&D expenditure is at least 30% of total relevant expenditure. |
| Ireland | Refundable: yes. The credit is paid in three instalments, irrespective of the company's corporation tax liability. | The first instalment is the greater of 50% of the claim or a fixed threshold (€75,000 for periods commencing on or after 1 January 2025 that end before 31 December 2026; €87,500 where the 35% rate applies). A credit that does not exceed the threshold is paid as a single instalment. |
| Canada | Refundable: for most CCPCs at the enhanced rate, current expenditure is 100% refundable and capital expenditure 40% refundable, up to the limit. | Enhanced rate of 35% on qualified expenditure up to the expenditure limit of C$6 million a year, for most CCPCs and eligible Canadian public corporations. |
| Australia | Refundable offset: corporate tax rate plus an 18.5% premium, for aggregated turnover under A$20 million. | At least A$20,000 of eligible R&D in the income year, unless you use a research service provider or contribute to the Cooperative Research Centres Program. |
| New Zealand | Refundable: in some cases. Refunds are capped, including by reference to labour-related taxes. | The cap is the total of the person's PAYE, employer superannuation contribution tax and fringe benefit tax for the year. Minimum spend NZ$50,000 a year, unless you use an approved research provider. |
| Singapore | Cash payout: optional. 20% of up to S$100,000 of qualifying expenditure across EIS activities, so up to S$20,000 per Year of Assessment. No refund of the deduction itself. | At least three full-time local employees, each earning a gross monthly salary of at least S$1,400. Expenditure converted into a cash payout is not also deductible. |
From headline rate to cash
Four adjustments stand between the rate in the table and the amount a founder can put in a cash flow forecast.
- The base. The rate applies to eligible costs, not total spend; Module 2 shows how to capture them.
- Tax on the benefit. In the United Kingdom the expenditure credit is taxable: for loss-making companies notional tax is deducted at the small profits rate (19 percent), giving a net benefit of 16.2 percent. Singapore's cash payout is not taxable income of the business.
- Caps. The United Kingdom and New Zealand cap the payment by reference to payroll taxes, Singapore by a fixed annual amount, and the United States by an annual limit on the payroll offset.
- Timing. A refund follows the return and any registration or approval step; Ireland pays in instalments. Module 4 sets out the order of events.
When the effort is not justified
A claim costs the time of the people who did the work, the time of whoever assembles the costs, and any advisor fee. These signals say when that cost is unlikely to be repaid.
| Signal | Why it matters | What to do |
|---|---|---|
| Spend is below a minimum threshold | Australia requires at least A$20,000 of eligible R&D in the income year and New Zealand at least NZ$50,000, each with a research provider exception. | Wait until the threshold is reached, or check the research provider route. |
| The work applied known methods | All seven schemes require a scientific or technological uncertainty; applying known methods to build a new product does not meet that test. | Read the guide on qualifying versus non-qualifying activities. |
| Someone else bears the risk or owns the results | Customer-funded and grant-funded work is excluded, reduced or clawed back in most of the seven countries. | Work through Module 3 first. |
| No records were kept and none can be reconstructed | Every scheme expects records made at the time that show the uncertainty, the work done to resolve it and the costs. | Set up the habits in Module 2 and claim for the next period. |
| The benefit is a deduction and the cash payout is not available | A deduction has no value until there is profit to set it against, and losses carried forward may be subject to a shareholding test. | Model when profit arrives and what a funding round does to the carry forward. |
| Preparation cost approaches the benefit | Fees vary widely. Contingent fees are commonly quoted as a percentage of the benefit, while fixed and hourly fees are also used, sometimes in combination. The fee model shapes the advice you receive, so understand what you are being offered. | Estimate internal time honestly and read the guide on briefing an advisor. |
Illustrative example
Illustrative example. Harbour Robotics Ltd, a hypothetical company, is pre-revenue, has no tax to pay, and spent 100,000 in its first year on engineers' salaries for work that resolved a technological uncertainty.
| If Harbour Robotics were in | Arithmetic | Cash now |
|---|---|---|
| Australia | Aggregated turnover under A$20 million; a base rate entity taxed at 25 percent has a refundable offset rate of 43.5 percent. A$100,000 at 43.5% = A$43,500. | A$43,500 refund, after registering the activities within 10 months of the end of the income year. |
| Ireland | 30% for accounting periods beginning on or after 1 January 2024. €100,000 at 30% = €30,000, below the first instalment threshold, so paid as a single instalment. | €30,000, after notifying the tax authority at least 90 days before the first claim. |
In the United States there is no refund, but a qualified small business can elect to apply the credit against payroll tax. The work to assemble the claim is the same in each case. The decision turns on the country's rules and on whether the uncertainty and the records can be shown, not on the size of the company.
Across the seven countries
Each country also sets a step a first-time claimant must take before the benefit can be claimed.
- United States: no pre-registration; the payroll tax election is made on a timely filed original return.
- United Kingdom: claim notification within 6 months of the end of the period of account, for a first claim or none in the last 3 years.
- Ireland: notify in advance, at least 90 days before the claim, for a first claim or none in the previous 3 years.
- Canada: no registration; optional pre-claim approval since 1 April 2026.
- Australia: register R&D activities with the department within 10 months of the end of the income year, every year.
- New Zealand: general approval before the claim; apply by the last day of the 3rd month after the end of the income year.
- Singapore: no registration; the cash payout needs at least three full-time local employees.
Where to go next
Self-check questions
Answer each question, then open it to compare.
A company has no tax to pay this year. Which three features of a scheme decide whether its claim is worth anything now rather than in some future year?
Which two countries cap the cash payment by reference to payroll taxes, and how is each cap described?
Name the two countries with a minimum annual spend before a claim is possible, and the exception each allows.
Why is Singapore's benefit valued differently from a credit, and what can a loss-making Singapore company receive in cash?
Give three signals that a first claim is not justified yet.
Official sources
- About Form 8974, Qualified Small Business Payroll Tax Credit for Increasing Research ActivitiesInternal Revenue Service
- R&D tax relief: the merged R&D expenditure credit scheme and enhanced R&D intensive supportGOV.UK
- Research and Development (R&D) Corporation Tax creditRevenue Commissioners
- Get an investment tax credit (ITC)Canada Revenue Agency
- Rates of R&D tax incentive offsetAustralian Taxation Office
- Enterprise Innovation Scheme (EIS)Inland Revenue Authority of Singapore
Register interest in Startups and Scale-ups
Tell us where you claim and we will let you know when this program opens for your country.
Educational content only, not tax advice. See the disclaimer.